Pliant Therapeutics (PLRX) PT Raised to $45 at Stifel following data
Tweet Send to a Friend
Stifel analyst Alex Thompson raised the price target on Pliant Therapeutics (NASDAQ: PLRX) to $45.00 (from $33.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
